Your browser doesn't support javascript.
loading
Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise.
Stocks, Ben; Ashcroft, Stephen P; Joanisse, Sophie; Dansereau, Linda C; Koay, Yen Chin; Elhassan, Yasir S; Lavery, Gareth G; Quek, Lake-Ee; O'Sullivan, John F; Philp, Ashleigh M; Wallis, Gareth A; Philp, Andrew.
Afiliação
  • Stocks B; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.
  • Ashcroft SP; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.
  • Joanisse S; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.
  • Dansereau LC; Mitochondrial Metabolism and Ageing Laboratory, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Koay YC; St Vincent's Clinical School, UNSW Medicine, UNSW Sydney, Sydney, Australia.
  • Elhassan YS; Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia.
  • Lavery GG; Heart Research Institute, University of Sydney, Sydney, NSW, Australia.
  • Quek LE; Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK.
  • O'Sullivan JF; Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK.
  • Philp AM; Charles Perkins Centre, School of Mathematics and Statistics, University of Sydney, Sydney, NSW, Australia.
  • Wallis GA; Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia.
  • Philp A; Heart Research Institute, University of Sydney, Sydney, NSW, Australia.
J Physiol ; 599(5): 1513-1531, 2021 03.
Article em En | MEDLINE | ID: mdl-33492681
ABSTRACT
KEY POINTS Acute nicotinamide riboside (NR) supplementation does not alter substrate metabolism at rest, during or in recovery from endurance exercise. NR does not alter NAD+ -sensitive signalling pathways in human skeletal muscle. NR supplementation and acute exercise influence the NAD+ metabolome. ABSTRACT Oral supplementation of the NAD+ precursor nicotinamide riboside (NR) has been reported to alter metabolism alongside increasing sirtuin (SIRT) signalling and mitochondrial biogenesis in rodent skeletal muscle. However, whether NR supplementation can elicit a similar response in human skeletal muscle is unclear. This study assessed the effect of 7-day NR supplementation on whole-body metabolism and exercise-induced mitochondrial biogenic signalling in skeletal muscle. Eight male participants (age 23 ± 4 years, V̇O2peak 46.5 ± 4.4 ml kg-1  min-1 ) received 1 week of NR or cellulose placebo (PLA) supplementation (1000 mg day-1 ). Muscle biopsies were collected from the medial vastus lateralis prior to supplementation and pre-, immediately post- and 3 h post-exercise (1 h of 60% Wmax cycling) performed following the supplementation period. There was no effect of NR supplementation on substrate utilisation at rest or during exercise or on skeletal muscle mitochondrial respiration. Global acetylation, auto-PARylation of poly ADP-ribose polymerase 1 (PARP1), acetylation of Tumour protein 53 (p53)Lys382 and Manganese superoxide dismutase (MnSOD)Lys122 were also unaffected by NR supplementation or exercise. NR supplementation did not increase skeletal muscle NAD+ concentration, but it did increase the concentration of deaminated NAD+ precursors nicotinic acid riboside (NAR) and nicotinic acid mononucleotide (NAM) and methylated nicotinamide breakdown products (Me2PY and Me4PY), demonstrating the skeletal muscle bioavailability of NR supplementation. In summary, 1 week of NR supplementation does not alter whole-body metabolism or skeletal muscle signal transduction pathways implicated in the mitochondrial adaptation to endurance exercise.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Niacinamida / Músculo Esquelético Tipo de estudo: Clinical_trials Idioma: En Revista: J Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Niacinamida / Músculo Esquelético Tipo de estudo: Clinical_trials Idioma: En Revista: J Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido